Answers are grounded in this paper and cite their sources.
Multimodal artificial intelligence (MMAI) is redefining oncology by integrating heterogeneous datasets from diagnostic modalities into cohesive analytical frameworks for more accurate and personalized cancer care. We highlight MMAI applications across the patient journey and clinical research, discuss outstanding challenges, and the need for guidelines and regulatory frameworks. By converting multimodal complexity into clinically actionable insights, MMAI is poised to improve patient outcomes while reshaping the economics of global cancer care.
No takes yet. Share an insight, caveat, or question.
Dellamonica et al. (2025) studied this question.